Data from Metabolomic Profiling Reveals Potential Markers and Bioprocesses Altered in Bladder Cancer Progression
Nagireddy Putluri(Baylor College of Medicine), Arun Sreekumar(University of Michigan–Ann Arbor), Christopher T. Tallman(Ann Arbor Center for Independent Living), Charles E. Butler(The University of Texas MD Anderson Cancer Center), Srilatha Nalluri(Augusta University), George Michailidis(University of Michigan), Alon Z. Weizer(University of Michigan), Gabriel Sica(Emory University), Vasanta Putluri(Baylor College of Medicine), Katrin Panzitt(Baylor College of Medicine), Yair Lotan(Southwestern Medical Center), Steven M. Fischer(Agilent Technologies (United States)), Ganesh S. Palapattu(University of Michigan), Ali Shojaie(University of Michigan–Ann Arbor), Huidong Shi(Augusta University), Daniel J. Brat(Northwestern University), Shahrokh F. Shariat(Universitätszahnklinik Wien), Martha K. Terris(WellStar Health System), Vihas T. Vasu(University of California, Davis), Theodore R. Sana(Agilent Technologies (United States)), Shaiju K. Vareed(Augusta University), Gagan Thangjam(Old Dominion University)
Cited by 0
Related Papers
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
|Nature|2008|7.8k
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
|Cell|2016|2.4k
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
|Nature Immunology|2001|1k
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
|Proceedings of the National Academy of Sciences|2017|899